-
Improving Quality of Life in LR-MDS Through Anemia Treatment
19 Apr 2025 02:57 GMT
… /Medical Oncologist
Rocky Mountain Cancer Centers
Aurora … thinking about imetelstat [Rytelo]. Imetelstat is a telomerase … treatment. Right now, at Rocky Mountain Cancer Centers … , Inc., GlaxoSmithKline, Novartis Pharmaceuticals Corp., OncoVerity, Inc., …
-
Geron Corporation Sued for Securities Law Violations - Contact Levi & Korsinsky Before May 12, 2025 to Discuss Your Rights – GERN
24 Apr 2025 16:27 GMT
… and growth potential of Rytelo (imetelstat). Defendants’ statements included, … unmet need for the drug and to execute on … existing competition on the drug’s sales. On February … monitoring requirement necessary for the drug treatment. Following this news, the …
-
Biotech giant Geron Crop accused of false Rytelo hype
15 Mar 2025 03:58 GMT
… Foster City biotech company specializing in drugs that fight blood cancer, was accused … "first-in-class" drug. They seek damages after the … 's latest medications Rytelo, whose generic name is imetelstat. The company …
-
RNA Therapeutics: Four Key Modalities Reshaping Medicine
12 Mar 2025 11:22 GMT
… cancer treatment in mice. By 2013, the first clinical trial … mRNA vaccines: a biotech and industrial perspective. npj Vaccines.
2020 … Drug trials snapshots: IZERVAY. FDA. https://www.fda.gov/drugs/drug-approvals-and-databases/drug-trials …
-
Imetelstat Earns EU Approval for Transfusion-Dependent Anemia in Lower-Risk MDS
12 Mar 2025 20:54 GMT
… the phase 3 IMerge trial (NCT02598661) supported this … treatment of lower-risk MDS,” Uwe Platzbecker, MD, chief medical … in our clinical trials and we look … www.fda.gov/drugs/;resources-information-approved-drugs/fda-approves-imetelstat-low …
-
Geron Announces European Commission Approval of RYTELO® (imetelstat), a First-in-Class Telomerase Inhibitor, for the Treatment of Adults With Transfusion-Dependent Anemia Due to Lower-Risk MDS
11 Mar 2025 20:38 GMT
… changing the course of blood cancer, today announced that the … demonstrated in our clinical trials and we look forward … EMA’s Committee of Orphan Medicinal Products (COMP) reviewed and … safety or efficacy results of imetelstat treatment cause the benefit-risk …
-
GERNON CORPORATION INVESTORS: Contact Robbins LLP to Lead the Class Action Against GERN
23 Apr 2025 19:00 GMT
… blood cancer. Geron’s primary product is a telomerase inhibitor, imetelstat, which … significant unmet need for the drug, particularly among first-line patients … monitoring requirement necessary for the drug treatment. On this news, the price …
-
Investors in Geron Corporation Should Contact The Gross Law Firm Before May 12, 2025 to Discuss Your Rights – GERN
23 Apr 2025 17:17 GMT
… and growth potential of Rytelo (imetelstat). Defendants’ statements included, … unmet need for the drug and to execute on … existing competition on the drug’s sales. On February … monitoring requirement necessary for the drug treatment. Following this news, the …
-
S2 Episode 1: What's Next? Clinical Trials in Myelofibrosis
06 Mar 2025 15:16 GMT
… cancer programs, along with being Charles Spurr, MD, Professor of Internal Medicine … part of myelofibrosis drug trials or clinical trials?
Mesa: It … imetelstat phase 3 study, but this was a trial … Ruxolitinib in JAK Inhibitor Treatment-Naive Myelofibrosis
Study …
-
Yang Highlights Positive COMMANDS Trial Data for Luspatercept in MDS
20 Feb 2025 00:44 GMT
… University School of Medicine
Karmanos Cancer Institute
Detroit, MI … treatment options. But what if your EPO is greater than 500? Imetelstat … design of the COMMANDS trial?
This study looked … achieved transfusion independence, treatment should be discontinued, …
About
© 1995-2025